Metacrine Inc

-0.02 (-3.60%)
3:59:31 PM EDT: $0.41 -0.02 (-4.17%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Metacrine Inc Stock, NASDAQ:MTCR

4225 Executive Square, Suite 600, San Diego, California 92037
United States of America
Phone: +1.858.369.7800
Number of Employees: 32


Metacrine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases. It offers farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.